Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity von Porta, Camillo, Giglione, Palma, Liguigli, Wanda, Paglino, Chiara

Volltext

Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis von Iacovelli, Roberto, Nolè, Franco, Verri, Elena, Renne, Giuseppe, Paglino, Chiara, Santoni, Matteo, Cossu Rocca, Maria, Giglione, Palma, Aurilio, Gaetano, Cullurà, Daniela, Cascinu, Stefano, Porta, Camillo

Volltext

Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib von Porta, Camillo, Paglino, Chiara, De Amici, Mara, Quaglini, Silvana, Sacchi, Lucia, Imarisio, Ilaria, Canipari, Cinzia

Volltext

Changes in Circulating Pro-Angiogenic Cytokines, other than VEGF, before Progression to Sunitinib Therapy in Advanced Renal Cell Carcinoma Patients von Porta, Camillo, Paglino, Chiara, Imarisio, Ilaria, Ganini, Carlo, Sacchi, Lucia, Quaglini, Silvana, Giunta, Vania, De Amici, Mara

Volltext

Identification of transcriptionally active HPV infection in formalin-fixed, paraffin-embedded biopsies of oropharyngeal carcinoma von Morbini, Patrizia, MD, Alberizzi, Paola, BS, Tinelli, Carmine, MD, Paglino, Chiara, MD, Bertino, Giulia, MD, Comoli, Patrizia, MD, Pedrazzoli, Paolo, MD, Benazzo, Marco, MD

Volltext

Could Interferon Still Play a Role in Metastatic Renal Cell Carcinoma? A Randomized Study of Two Schedules of Sorafenib Plus Interferon-Alpha 2a (RAPSODY) von Bracarda, Sergio, Porta, Camillo, Boni, Corrado, Santoro, Armando, Mucciarini, Claudia, Pazzola, Antonio, Cortesi, Enrico, Gasparro, Donatello, Labianca, Roberto, Di Costanzo, Francesco, Falcone, Alfredo, Cinquini, Michela, Caserta, Claudia, Paglino, Chiara, De Angelis, Verena

Volltext

Targeting PI3K/Akt/mTOR Signaling in Cancer von Porta, Camillo, Paglino, Chiara, Mosca, Alessandra

Volltext

Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy von Porta, Camillo, Paglino, Chiara, Imarisio, Ilaria, Canipari, Cinzia, Chen, Kristina, Neary, Maureen, Duh, Mei Sheng

Volltext

Immunological effects of multikinase inhibitors for kidney cancer: a clue for integration with cellular therapies? von Porta, Camillo, Paglino, Chiara, Imarisio, Ilaria, Ganini, Carlo, Pedrazzoli, Paolo

Volltext

Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib von Porta, Camillo, Paglino, Chiara

Volltext

Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma von Porta, Camillo, Paglino, Chiara, Mutti, Luciano

Volltext

Raltitrexed–Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients von Porta, Camillo, Zimatore, Matteo, Bonomi, Lucia, Imarisio, Ilaria, Paglino, Chiara, Sartore-Bianchi, Andrea, Mutti, Luciano

Volltext

Experience Gathered from Retrospective Series on Renal Cell Carcinoma Is Useful, But Now It Is Time for a Global Claim for Academically Driven Prospective Studies von Porta, Camillo, Paglino, Chiara

Volltext

Cytokine-based immunotherapy for advanced kidney cancer: past results and future perspectives in the era of molecularly targeted agents von Porta, Camillo, Paglino, Chiara, Imarisio, Ilaria, Bonomi, Lucia

Volltext

Renal Cell Carcinoma-induced Immunosuppression: An Immunophenotypic Study of Lymphocyte Subpopulations and Circulating Dendritic Cells von PORTA, Camillo, BONOMI, Lucia, ROVERETO, Bruno, LILLAZ, Beatrice, PAGLINO, Chiara, ROVATI, Bianca, IMARISIO, Ilaria, MORBINI, Patrizia, VILLA, Chiara, DANOVA, Marco, MENSI, Mario

Volltext

Lingual Metastasis from Renal Cell Carcinoma: A Case Report and Literature Review von Ganini, Carlo, Lasagna, Angioletta, Ferraris, Elisa, Gatti, Patrizia, Paglino, Chiara, Imarisio, Ilaria, Morbini, Patrizia, Benazzo, Marco, Porta, Camillo

Volltext

TREATMENT OF METASTATIC RENAL CARCINOMA PATIENTS WITH THE COMBINATION OF GEMCITABINE, CAPECITABINE AND BEVACIZUMAB AT A TERTIARY CANCER CENTRE von Porta, Camillo, Paglino, Chiara

Volltext

Slow and Steady Wins the Race: Practical (and Philosophical) Considerations of Treatment Activity Evaluation When Novel Anticancer Agents Just Slow Neoplastic Progression von Porta, Camillo, Vercelli, Alessandro, Paglino, Chiara

Volltext

SORAFENIB RECHALENGE IN METASTATIC RENAL CELL CARCINOMA von Porta, Camillo, Paglino, Chiara, Imarisio, Ilaria

Volltext

Sequential use of sorafenib and sunitinib in advanced renal‐cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases von Porta, Camillo, Procopio, Giuseppe, Cartenì, Giacomo, Sabbatini, Roberto, Bearz, Alessandra, Chiappino, Isabella, Ruggeri, Enzo Maria, Re, Giovanni Lo, Ricotta, Riccardo, Zustovich, Fable, Landi, Lorenza, Calcagno, Anna, Imarisio, Ilaria, Verzoni, Elena, Rizzo, Mimma, Paglino, Chiara, Guadalupi, Valentina, Bajetta, Emilio

Volltext